Suzannah J. Harnor
Newcastle University(GB)
Publications by Year
Research Areas
Cancer-related Molecular Pathways, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Melanoma and MAPK Pathways, DNA Repair Mechanisms
Most-Cited Works
- → Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines(2016)113 cited
- → Targeting DNA‐Dependent Protein Kinase for Cancer Therapy(2017)77 cited
- → Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein–Protein Interaction(2021)52 cited
- → Human Toxicity Caused by Indole and Indazole Carboxylate Synthetic Cannabinoid Receptor Agonists: From Horizon Scanning to Notification(2017)29 cited
- → Advanced approaches of developing targeted covalent drugs(2022)28 cited
- → Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4(2019)22 cited
- → Modulation of ERK5 Activity as a Therapeutic Anti-Cancer Strategy(2023)21 cited
- → 2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase(2020)18 cited
- → Structure-activity analysis of CJ-15,801 analogues that interact with Plasmodium falciparum pantothenate kinase and inhibit parasite proliferation(2017)17 cited
- → An Alkynylpyrimidine-Based Covalent Inhibitor That Targets a Unique Cysteine in NF-κB-Inducing Kinase(2021)16 cited